Skip to main content
. 2026 Mar 20;11(4):106899. doi: 10.1016/j.esmoop.2026.106899

Figure 3.

Figure 3

Outcomes by baseline CDH18 status. (A) PFS and (B) OS in the intent-to-treat population by CDH18 status. Patients positive of CDH18 in pretreatment samples had significantly longer PFS and OS. CI, confidence interval; OS, overall survival; PFS, progression-free survival.